SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing tarumase (provisional INN), a recombinant enzyme derived from maggots, and which aims to accelerate wound ...
SolasCure Completes Phase II Clinical Trial, Demonstrating Accelerated Healing With Aurase Wound Gel
The MarketWatch News Department was not involved in the creation of this content. -- Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous ...
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced that the US Food and Drug Administration (FDA) has granted Fast ...
Acting as the main interface between the internal and the external world, the skin is the largest and most important organ of the human body. It is frequently exposed to many types of physical ...
Pairing esmolol hydrochloride topical gel treatment with standard wound care resulted in significantly greater diabetic foot wound closure compared to standard wound care alone, the results of a ...
As aging populations and rising diabetes rates drive an increase in chronic wounds, more patients face the risk of amputations. UC Riverside researchers have developed an oxygen-delivering gel capable ...
Researchers from the Department of Mechanical Engineering at the University of Hong Kong (HKU) have recently achieved a remarkable breakthrough in the injectable hydrogel with the development of Fibro ...
RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--Applied Medical is commemorating 20 years of wound protection since the first Alexis wound protector-retractor was introduced. The Alexis brand is ...
The global Hydrogels for Medical Application Market, valued at USD 1.50 billion in 2025, is entering a sustained scaling phase as clinical adoption of hydrogel-based platforms accelerates across ...
Most small wounds heal naturally with time, but home remedies — such as aloe vera, antibacterial ointment, or honey — may speed up the healing process. A wound leaves the body’s internal tissues ...
Phase IIa clinical trial evaluated Aurase Wound Gel in patients with venous leg ulcers Former Smith+Nephew CMO, Andy Weymann joins as Chairman to support progression of further Phase II clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results